PRZOOM - /newswire/ -
Chalfont St Giles, United Kingdom, 2012/07/30 - GE Healthcare Life Sciences, a business unit of GE Healthcare and NetBio, announced an alliance to commercialize new, fast, cost effective and easy-to-use DNA sample collection and analysis products for the forensic market (NYSE: GE) - NetBio.com. NYSE: GE
GE Healthcare Life Sciences, a business unit of GE Healthcare (NYSE: GE) and NetBio, a leading provider of technologies for the emerging field of Rapid DNA Analysis, announced today an alliance to commercialize new, fast, cost effective and easy-to-use DNA sample collection and analysis products for the forensic market. The alliance will combine the global distribution reach and the world-class sample collection capabilities of GE Healthcare Life Sciences with NetBio’s innovative DNA analysis technologies to provide advanced products for DNA fingerprinting, helping to make the process easier and quicker than current methods. DNA fingerprinting is widely used by law enforcement agencies and forensic laboratories to identify potential suspects and to support criminal investigations. Financial terms were not disclosed.
Commenting on the alliance, Eric Roman, General Manager, Global Commercial Operations, GE Healthcare Life Sciences said,“We’re delighted to announce this alliance with NetBio. We’re excited at the potential of combining the scientific expertise and capabilities of both companies with GE’s global resources in order to commercialize innovative products for use in the forensic setting.”
Dr. James Schumm, Vice President of Molecular Biology, NetBio added: “NetBio’s technology is based on combining a large number of complex DNA processing steps into a fully-automated, fully-integrated system for Rapid DNA Analysis. DNA analysis has revolutionized the field of forensics over the past two decades, and partnering with GE Healthcare has the potential to accelerate the pace of this revolution by commercializing products that will provide law enforcement agencies and forensic laboratories with faster results.”
About GE Healthcare
GE Healthcare (gehealthcare.com) provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.
Founded based on pioneering microfluidic research performed at MIT's Whitehead Institute, NetBio (netbio.com) was incorporated in 2000 in Greater Boston and has received significant support from both industry and government agencies. NetBio has developed a series of enabling microfluidic and molecular biology technologies applicable to both forensics and clinical diagnostics. These enabling technologies include sample preparation and DNA purification, rapid thermal cycling, highly multiplexed amplification, focused DNA sequencing, optical detection of DNA sequences, signal processing, and nucleic acid separation and detection. NetBio's products have been designed for use by non-technical operators outside the laboratory, a feature that is critical to address the enormous unmet needs of the rapidly emerging Rapid DNA Analysis markets.